Buda Juice delivered the kind of quarter that small-cap growth stories need after a rocky post-IPO stretch. Earnings of $0.07 per share topped the $0.02 consensus by 250.0%. Revenue of $5.21 million beat the $4.4 million estimate by 18.3%. More important than the size of the beat was the trajectory. Revenue rose 64% year-over-year, according to the company, after gains of 17.7% in the first quarter and 26.4% in the second. When management reported second-quarter results in August, it said quarter-to-date sales were running up more than 40%. It finished well above that pace. The central takeaway is clear acceleration in sales and a sharp sequential recovery in profitability. The tension is that margins and GAAP net income still look weaker than they did a year ago.

The quality of the beat deserves some scrutiny. Same-store sales in the core beverage business grew a healthy 23%, up from the roughly 20% trend referenced on the second-quarter call. That figure is well below the 64% headline, however. A meaningful share of the growth came from the first full quarter of Buda Fresh distribution in 246 Walmart stores and from the refrigerated dressings business acquired in May. Gross margin recovered 417 basis points sequentially to 40.8% as lime and produce costs normalized. It remained 367 basis points below the 44.5% posted a year earlier, reflecting interim third-party co-packing costs for dressings and higher diesel prices. Operating expenses climbed to 21.7% of revenue from 17.0%, driven by public-company costs, stock compensation and distribution. Operating income rose only modestly, to $996,000 from $870,000. Pre-tax income grew 28%, helped by $139,000 of interest income on IPO proceeds. Net income of $866,000 was essentially flat with last year's $881,000 because the company now pays corporate taxes after converting to a C corporation. Adjusted EBITDA grew 35% to $1.3 million, but its margin slipped to roughly 25% from 30.5%.

Sequentially, the picture is far stronger, and that is what the call emphasized:

• Adjusted EBITDA rose about 80% from the second quarter's $0.7 million.
• Net income improved from roughly $0.5 million, or $0.04 per share.
• Operating cash flow swung from an outflow of $365,000 to an inflow of about $710,000.
• Cash rose to $19.3 million, with no debt and an undrawn $3 million revolver.

One balance-sheet item merits watching. Receivables have grown sharply since year-end, including $790,000 owed by a related party. As a result, nine-month operating cash flow of $1.65 million trails the prior-year period despite much higher sales.

The most tangible forward catalyst is the in-house dressings line at the Dallas facility. The line passed an SQF audit with a score of 97 out of 100, and production remains on track to begin transitioning in the first quarter of 2027. Management expects the move to eliminate roughly 320 basis points of co-packing drag. If that happens, much of the year-over-year margin gap closes mechanically. Management also discussed several growth opportunities:

• a Walmart SKU change to lemonade and strawberry lemonade at $1.28, with talks about additional SKUs and stores;
• new dressing flavors;
• East Coast customer discussions;
• a possible demand-driven regional plant "hopefully next year."

Bears still have legitimate ammunition. The company offers no formal guidance and declined to frame the fourth quarter. The diesel headwind has no visible end date. Customer concentration and Walmart execution details were withheld as proprietary. Any regional plant would require capital.

The market setup is more complicated than the surprise implies. Shares closed at $7.20 heading into the report, down 16.8% from the $8.65 opening after the August release. The stock peaked at $9.65 on August 17 before sliding to a $6.25 low on October 22. It entered the print about 25% below that high and roughly 15% above the low, meaning it had already rebounded somewhat off the bottom. Investor sentiment stood at a mildly negative -0.20, suggesting expectations were cautious rather than euphoric. The Earnings Whispers trend readings are mixed, with momentum positive while AVWAP remains negative. That fits a stock trying to stabilize after a post-report fade.

The bottom line is that Buda Juice answered the growth question convincingly. Accelerating revenue, a 23% same-store figure and a sequential margin rebound give the story more substance than the August report did. The quality caveats remain, though. Growth is partly inorganic, gross and EBITDA margins are below last year's levels, and GAAP earnings are flat once taxes and public-company costs are included. Management has also withheld guidance. The next proof point is the first-quarter 2027 dressings insourcing. If that delivers the promised margin lift while Walmart and same-store momentum hold, the year-over-year comparisons that still weigh on this quarter should begin to work in the company's favor.